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Abstract 
CCDC6 was originally identified upon rearrangement with RET in human thyroid papillary carcinomas generating the 
RET/PTC1 oncogene. We have previously reported that CCDC6 interacts with CREB1 and represses its transcriptional 
activity. Since the function of at least one allele of CCDC6 is lost following RET/PTC1 rearrangements, we aimed at 
the generation of mice, carrying a CCDC6 mutant gene. Previous studies suggested that the coiled-coil domain of 
CCDC6, mainly encoded by human exon 2, is required for the protein function. Therefore, we engineered a murine 
Ccdc6 construct, carrying a deletion of the exon 2, that was able to exert only a mild repression on CREB1 
transcriptional activity, with respect to the wild type Ccdc6. Subsequently, we generated Ccdc6-ex2 knock-in mice. 
These mice developed thyroid hyperplasia associated with an enhanced CREB1 activity and an increased expression of 
the CREB-1 regulated genes. These results strongly support a CCDC6 promoting role, ascribed to its functional 
impairment, in the development of thyroid papillary carcinomas harboring the RET/PTC1 oncogene. 
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